Matsumoto, Japan

Yuko Wada

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Anaeropharma Science, Inc., Shinshu University. Active years: 2017-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuko Wada. Retrieved from https://idiyas.com/inventor/yuko-wada-wnup79d0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile




Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Nagano, JP (2017)
  • Matsumoto, JP (2021)

Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuko Wada: Innovator in Therapeutic Agents for Ischemic Diseases

Introduction

Yuko Wada is a prominent inventor based in Matsumoto, Japan. He has made significant contributions to the field of medical technology, particularly in the development of therapeutic agents for ischemic diseases. With a total of 2 patents, Wada's work focuses on innovative gene transfer carriers that enhance treatment efficacy.

Latest Patents

Wada's latest patents include groundbreaking advancements in therapeutic agents for ischemic diseases. One patent provides a transformation plasmid designed for transforming anaerobes, enabling highly efficient and stable secretory expression of target proteins. This innovation includes a gene delivery carrier formed from the transformed anaerobes, a pharmaceutical composition containing this carrier, and methods for diagnosing or treating ischemic diseases. Another patent aims to create a gene transfer carrier that specifically accumulates at disease sites, ensuring high protein expression rates and facilitating effective treatment methods for ischemic conditions.

Career Highlights

Throughout his career, Wada has worked with notable organizations such as Anaeropharma Science, Inc. and Shinshu University. His experience in these institutions has allowed him to refine his research and contribute to advancements in medical therapies.

Collaborations

Wada has collaborated with several professionals in his field, including Yuko Shimatani-Shibata and Hitomi Shimizu-Matsuhashi. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yuko Wada's contributions to the development of therapeutic agents for ischemic diseases highlight his role as a leading inventor in the medical field. His innovative approaches and collaborations continue to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…